0001628280-24-050104.txt : 20241205 0001628280-24-050104.hdr.sgml : 20241205 20241205170235 ACCESSION NUMBER: 0001628280-24-050104 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241101 FILED AS OF DATE: 20241205 DATE AS OF CHANGE: 20241205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krogulski Kenneth CENTRAL INDEX KEY: 0001695580 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 241529809 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE, SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 wk-form4_1733436149.xml FORM 4 X0508 4 2024-11-01 0 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001695580 Krogulski Kenneth 1600 WEST END AVE., SUITE 1300 NASHVILLE TN 37203 1 0 0 0 1 Common Stock 2024-11-01 5 P 0 E 380 1.15 A 263978 D Common Stock 2024-11-04 5 P 0 E 245 1.17 A 264223 D Common Stock 2024-11-05 5 P 0 E 380 1.20 A 264603 D Common Stock 2024-11-06 5 P 0 E 380 1.20 A 264983 D Common Stock 2024-11-07 5 P 0 E 380 1.17 A 265363 D Common Stock 2024-11-08 5 P 0 E 380 1.18 A 265743 D Common Stock 2024-11-11 5 P 0 E 380 1.20 A 266123 D Common Stock 2024-11-12 5 P 0 E 380 1.20 A 266503 D Common Stock 2024-11-13 5 P 0 E 380 1.20 A 266883 D Common Stock 2024-11-14 5 P 0 E 380 1.19 A 267263 D Common Stock 2024-11-15 5 P 0 E 380 1.17 A 267643 D Common Stock 2024-11-18 5 P 0 E 380 1.18 A 268023 D Common Stock 2024-11-19 5 P 0 E 380 1.15 A 268403 D Common Stock 2024-11-20 5 P 0 E 427 1.13 A 268830 D Common Stock 2024-11-21 5 P 0 E 427 1.09 A 269257 D Common Stock 2024-11-22 5 P 0 E 474 1.07 A 269731 D Common Stock 2024-11-25 5 P 0 E 474 1.09 A 270205 D Common Stock 2024-11-26 5 P 0 E 474 1.11 A 270679 D Common Stock 2024-11-27 5 P 0 E 474 1.15 A 271153 D Common Stock 2024-11-29 5 P 0 E 474 1.32 A 271627 D The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact 2024-12-05